Cite
HARVARD Citation
Pagare, P. et al. (2022). Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property. Expert opinion on therapeutic patents. pp. 115-130. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pagare, P. et al. (2022). Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property. Expert opinion on therapeutic patents. pp. 115-130. [Online].